Faropenem daloxate 37-01 CS(=O)(=O)CCCOC1=CC(C)=C(C2=CC(COC3=CC4OC[C@@H](CC(O)=O)C=4C=C3)=CC=C2)C(C)=C1

CS(=O)(=O)CCCOC1=CC(C)=C(C2=CC(COC3=CC4OC[C@@H](CC(O)=O)C=4C=C3)=CC=C2)C(C)=C1

while Hesperadin (IC50 = 550 nM) and weakly inhibited the growth of insect circulation stage (PF) cells

The pharmacokinetic parameters of astilbin followed by intragastric administration astilbin (40 mg/kg): Cmax=37

Solubility: DMSO: 100 mg/mL(115

Faropenem daloxate 37-01 CS(=O)(=O)CCCOC1=CC(C)=C(C2=CC(COC3=CC4OC[C@@H](CC(O)=O)C=4C=C3)=CC=C2)C(C)=C1Faropenem medoxomil, also known as Faropenem daloxate or Faropenem medoxil, is an orally active beta lactam antibiotic belonging to the penem group. It is resistant to some forms of extended spectrum beta lactamase. Faropenem medoxomil is a prodrug of Faropenem. Product information CAS Number: 141702 36 5 Molecular Weight: 397. 40 Formula: C17H19NO8S Chemical Name: (5 methyl 2 oxo 2H 1,3 dioxol 4 yl)methyl (5R,6S) 6 [(1R) 1 hydroxyethyl] 7 oxo 3 [(2R)